ALXO Q1 2021 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$113M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-0.35

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$433M

Total Liabilities

$14M

Stockholders' Equity

$418M

Cash & Equivalents

$430M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$655,000	-100.0%
Gross Profit	$0	$59,000	-100.0%
Operating Income	-$14M	-$5M	-171.0%
Net Income	-$14M	-$5M	-160.1%